kits and reagents segment dominated the market with its largest revenue share contribution, owing to
the increasing use of consumables for mycoplasma analysis while conducting cell culture research work and related activities.
In terms of technology, the
Polymerase Chain Reaction (PCR) segment held the majority of the market share and is expected to constitute more than half of the market over the forecast period.
High specificity, efficiency, and preciseness are some of the key attributes that make PCR ideal for mycoplasma analysis.
Pharmaceutical & biotechnology companies market segment accounted for over 25% of the
revenue share in 2019 owing to the growing demand for mycoplasma testing for cell culture research and several research & development activities
Share:
“The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Charles River Laboratories International, Inc. (US), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), American Type Culture Collection (US), Bionique Testing Laboratories, Inc. (US), InvivoGen (US).”
Mycoplasma Testing Market Size Estimation and Analysis of Wide Range of Growth Opportunities for Industry Players.
The global mycoplasma testing market’s growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical R & D activities and investments.
Browse through 110 market data tables and 23 figures spread across 144 pages and the in-depth TOC of the mycoplasma testing market.